Black Hawk Acquisition Corp
corporate_fare Company Profile
Black Hawk Acquisition Corp (NASDAQ:BKHA) is a publicly traded company in the Life Sciences sector. Wiseek monitors BKHA SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Black Hawk Buys One More Month with $150K Trust Deposit
- Black Hawk Q2 Net Income Plunges 83% to $89K Amid SPAC Merger Uncertainty
- Black Hawk Flags Going Concern, Ineffective Controls, and Nasdaq Delisting Risk in Q2 10-Q
- SPAC Faces Delisting, Discloses Charter Breach, and Significant Dilution Risks in Merger with Pre-Clinical Biotech
- SPAC Merger Update: Black Hawk Details Governance Breach, Nasdaq Delisting Risk, and High Dilution in Vesicor Biotech Deal
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for BKHA, detected from its recent SEC filings · based on capital-structure filings through 2026-05-08.
Secures Convertible Note · Working Capital for DeSPAC
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →